Keyphrases
Heart Failure
86%
Heart Failure Patients
57%
Indonesia
52%
Meta-analysis
51%
Patients with Heart Failure
41%
Systematic Meta-analysis
31%
Heart Failure with Preserved Ejection Fraction (HFpEF)
30%
Clinical Outcomes
22%
Jakarta
21%
ST-elevation Myocardial Infarction (STEMI)
20%
Confidence Interval
19%
Acute Decompensated Heart Failure
19%
Type 2 Diabetes Mellitus (T2DM)
17%
Odds Ratio
17%
Hypertension
17%
Asia
16%
Rehospitalization
16%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
16%
Echocardiography
15%
In-hospital Mortality
15%
Left Ventricular Ejection Fraction
15%
Beta-blockers
15%
Asian Patients
14%
Type 1 Diabetes Mellitus (T1DM)
14%
Coronary Artery Disease
13%
Diabetes
13%
Hypertensive Patients
13%
COVID-19
13%
Primary Angioplasty
13%
Acute ST-segment Elevation Myocardial Infarction
12%
Review Analysis
12%
Rheumatic Mitral Stenosis
12%
Sudden Cardiac Death
12%
Clinical Characteristics
12%
Atrial Fibrillation
11%
Rheumatic Heart Disease
10%
Oxidized Low-density Lipoprotein (ox-LDL)
10%
Diabetes Mellitus Model
10%
Indonesian
10%
Functional Capacity
10%
Cardiovascular Center
9%
Left Ventricle
9%
Left Ventricular Function
9%
Prognostic Value
9%
Metabolic Syndrome
9%
Darapladib
9%
Cardiovascular Events
9%
Pulmonary Hypertension
8%
Angiotensin-converting Enzyme Inhibitor (ACEi)
8%
Body Mass Index
8%
Medicine and Dentistry
Congestive Heart Failure
100%
Meta-Analysis
44%
Systematic Review
34%
Cardiovascular System
26%
Heart Failure with Reduced Ejection Fraction
24%
Odds Ratio
23%
COVID-19
23%
ST Segment Elevation Myocardial Infarction
22%
Prevalence
15%
Diabetes Mellitus
15%
Mitral Valve Stenosis
14%
Echocardiography
14%
Angioplasty
13%
Heart Left Ventricle Ejection Fraction
13%
Quality of Life
12%
Myocardial Infarction
12%
Heart Failure with Preserved Ejection Fraction
12%
Percutaneous Coronary Intervention
12%
Pulmonary Hypertension
12%
Hospital Mortality
11%
Sudden Cardiac Death
11%
Acute Decompensated Heart Failure
11%
Ejection Fraction
11%
Coronary Artery Disease
11%
Blood Pressure
10%
Diabetes
10%
Mitral Insufficiency
10%
Functional Status
9%
Randomized Controlled Trial
9%
Atrial Fibrillation
9%
Metabolic Syndrome
9%
Lymphocyte
8%
Neutrophil
8%
Normal Tension Glaucoma
8%
Heart Work
8%
Mitral Valve Repair
8%
Rheumatic Heart Disease
7%
Infection
7%
Blood Clot Lysis
7%
Cardiovascular Disease
7%
Left Ventricle
7%
Comorbidity
7%
Right Ventricular Function
6%
Patient Referral
6%
Hazard Ratio
6%
Obstruction
6%
Acute Heart Infarction
6%
Echography
6%
Heart Left Ventricle Function
6%
Tissue Doppler Imaging
6%